AceLink Therapeutics is a startup biopharmaceutical company located in the San Francisco Bay Area. Our mission is to develop first-in-class and best-in-class drugs for genetically associated human diseases with the initial focus on a small molecule drug for polycystic kidney disease (PKD), a human genetic disease with 12 million patients worldwide.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 39600 Eureka Drive,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- acelinktherapeutics.com
- HQ
- Newark, CA
Acelink Therapeutics Questions
Acelink Therapeutics's website is acelinktherapeutics.com
Acelink Therapeutics's LinkedIn profile is https://www.linkedin.com/company/acelink-therapeutics
Acelink Therapeutics has
4 employees.
View email and phone details for 4
employees at Acelink Therapeutics.
Acelink Therapeutics's industry is
Pharmaceutical Manufacturing
Acelink Therapeutics's top competitors are
Affini-T Therapeutics,
Adiso Therapeutics,
Allievex Corporation,
Dinaqor,
Biomea Fusion,
Poxel,
Grace Science, Llc,
Verseon,
Rege Nephro Co., Ltd.,
Catailyst, Inc..
Acelink Therapeutics's categories are Pharmaceutical Manufacturing
Acelink Therapeutics's founding year is 2019
